Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10618973 Anti-HER2 glycoantibodies and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Academia Sinica
Academia Sinica
Date Filed
June 21, 2018
Date of Patent
April 14, 2020
Patent Applicant
Academia Sinica
Academia Sinica
Patent Application Number
16014255
Patent Citations
‌
US Patent 10118969 Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
‌
US Patent 10119972 Reactive labelling compounds and uses thereof
‌
US Patent 10130714 Enhanced anti-influenza agents conjugated with anti-inflammatory activity
‌
US Patent 10214765 Cell-permeable probes for identification and imaging of sialidases
‌
US Patent 10150818 Compositions and methods for treatment and detection of cancers
‌
US Patent 10005847 Anti-HER2 glycoantibodies and uses thereof
‌
US Patent 10023892 Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
‌
US Patent 10086054 RM2 antigens and use thereof
‌
US Patent 10087236 Methods for modifying human antibodies by glycan engineering
‌
US Patent 10111951 Human iNKT cell activation using glycolipids with altered glycosyl groups
Patent Citations Received
‌
US Patent 11377485 Methods for modifying human antibodies by glycan engineering
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10618973
Patent Primary Examiner
‌
Lynn A Bristol

Find more entities like US Patent 10618973 Anti-HER2 glycoantibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.